Jessica J. Jalbert, PhD (she/her/hers)

Executive Director
Regeneron Pharmaceuticals, Inc.

Poster(s):

• (106) Impact of allergic conditions on COVID-19 susceptibility and outcomes
  Monday, August 26, 2024

  8:00 AM – 6:00 PM CEST

• (132) The Association Between Asthma and Outcomes of COVID-19
  Monday, August 26, 2024

  8:00 AM – 6:00 PM CEST

• (257) Within-Trial Interviews to Contextualize the Patient Experience and Supplement Clinical Outcomes Assessments in a Pivotal Trial of a Newly Described, Fatal and Ultra-Rare Pediatric Disease
  Wednesday, August 28, 2024

  8:00 AM – 1:30 PM CEST